Results 311 to 320 of about 724,005 (372)

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao   +27 more
wiley   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi   +9 more
wiley   +1 more source

Three months of bempedoic acid treatment does not affect cystatin C-based estimation of glomerular filtration rate. [PDF]

open access: yesHigh Blood Press Cardiovasc Prev
Serio L   +7 more
europepmc   +1 more source

Relationships of Isolated Nocturnal Hypertension with Glomerular Filtration Rate and Albuminuria. [PDF]

open access: yesDiseases
Carollo C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy